Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Latest Information Update: 25 Oct 2023
At a glance
- Drugs Levetiracetam (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 19 Oct 2023 Planned End Date changed from 30 Sep 2023 to 30 Jun 2024.
- 19 Oct 2023 Planned primary completion date changed from 30 Sep 2023 to 30 Jun 2024.
- 19 Oct 2023 Status changed from recruiting to active, no longer recruiting.